High throughput screening for small molecule inhibitors of heparin-induced tau fibril formation

被引:85
作者
Crowe, Alex
Ballatore, Carlo
Hyde, Edward
Trojanowski, John Q.
Lee, Virginia M. -Y.
机构
[1] Univ Penn, Inst Aging, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA
关键词
microtubule associated protein tau; fibrillization; FTDP-17; Alzheimer's disease; high throughput screening; inhibitor;
D O I
10.1016/j.bbrc.2007.03.056
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A library of 51,000 compounds was interrogated by high throughput screening (HTS) using a heparin-induced tau fibrillization assay. HTS was conducted with bacterially expressed recombinant tau fragment K18 and the reaction was monitored by thioflavine T fluorescence. Hits meeting criteria set for selection in HTS were further evaluated in a panel of assays designed (a) to confirm the initial results and (b) to identify possible false positives arising from non-specific mechanisms or assay-dependent artifacts. Two 2,3-di(furan-2-yl)-quinoxalines were confirmed as inhibitors of tau fibrillization with IC(50)s in the low micromolar range (1-3 mu M). Among false positive hits, members of the pyrimidotriazines, benzofurans, porphyrins, and anthraquinone, inhibited tau fibrillization by generating peroxides via catalytic redox cycles due to the reducing agent dithiothreitol (DTT) in the assay. This study delineates focused strategies for HTS of tau fibrillization inhibitors that are relevant to drug discovery for Alzheimer's disease and related tauopathies. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:1 / 6
页数:6
相关论文
共 10 条
  • [1] Ligand-dependent inhibition and reversal of tau filament formation
    Chirita, C
    Necula, M
    Kuret, J
    [J]. BIOCHEMISTRY, 2004, 43 (10) : 2879 - 2887
  • [2] Identification of a novel class of orally active pyrimido[5,4-3][1,2,4]triazine-5,7-diamine-based hypoglycemic agents with protein tyrosine phosphatase inhibitory activity
    Guertin, KR
    Setti, L
    Qi, L
    Dunsdon, RM
    Dymock, BW
    Jones, PS
    Overton, H
    Taylor, M
    Williams, G
    Sergi, JA
    Wang, K
    Peng, Y
    Renzetti, M
    Boyce, R
    Falcioni, F
    Garippa, R
    Olivier, AR
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (17) : 2895 - 2898
  • [3] A specific mechanism of nonspecific inhibition
    McGovern, SL
    Helfand, BT
    Feng, B
    Shoichet, BK
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (20) : 4265 - 4272
  • [4] A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening
    McGovern, SL
    Caselli, E
    Grigorieff, N
    Shoichet, BK
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (08) : 1712 - 1722
  • [5] Anthraquinones inhibit tau aggregation and dissolve Alzheimer's paired helical filaments in vitro and in cells
    Pickhardt, M
    Gazova, Z
    von Bergen, M
    Khlistunova, I
    Wang, YP
    Hascher, A
    Mandelkow, EM
    Biernat, J
    Mandelkow, E
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (05) : 3628 - 3635
  • [6] Protein aggregation and neurodegenerative disease
    Ross, CA
    Poirier, MA
    [J]. NATURE MEDICINE, 2004, 10 (07) : S10 - S17
  • [7] Neurodegenerative diseases: New concepts of pathogenesis and their therapeutic implications
    Skovronsky, Daniel M.
    Lee, Virginia M. -Y.
    Trojanowskiz, John Q.
    [J]. ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE, 2006, 1 (01) : 151 - 170
  • [8] Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins
    Taniguchi, S
    Suzuki, N
    Masuda, M
    Hisanaga, S
    Iwatsubo, T
    Goedert, M
    Hasegawa, M
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (09) : 7614 - 7623
  • [9] Microtubule-stabilising drugs for therapy of Alzheimer's disease and other neurodegenerative disorders with axonal transport impairments
    Trojanowski, JQ
    Smith, AB
    Huryn, D
    Lee, VMY
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (05) : 683 - 686
  • [10] Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines
    Wischik, CM
    Edwards, PC
    Lai, RYK
    Roth, M
    Harrington, CR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (20) : 11213 - 11218